New Method for DNA Isolation from Blood Serum for Cancer Diagnostics
Author Information
Author(s): Wielscher Matthias, Pulverer Walter, Peham Johannes, Hofner Manuela, Rappaport Christine F, Singer Christian, Jungbauer Christof, Nöhammer Christa, Weinhäusel Andreas
Primary Institution: Austrian Institute of Technology
Hypothesis
Can a methyl-binding domain protein-based approach effectively isolate DNA from serum while retaining protein functionality for cancer diagnostics?
Conclusion
The MBD affinity purification method allows for effective DNA isolation from serum while preserving protein function, enhancing cancer diagnostic capabilities.
Supporting Evidence
- DNA levels were significantly higher in breast cancer patients compared to controls.
- The MBD method retained protein functionality for subsequent analyses.
- Autoantibody profiles were comparable between MBD processed and untreated serum samples.
- Serum DNA concentrations were found to be significantly elevated in patients with metastasizing breast cancer.
Takeaway
Scientists found a new way to get DNA from blood without messing up the proteins, which helps in finding cancer earlier.
Methodology
Serum and plasma samples were processed using either silica membrane-based or MBD affinity-based DNA isolation methods, followed by qPCR and protein microarray analyses.
Potential Biases
Potential bias in sample selection as all samples were from specific institutions.
Limitations
The study primarily focused on breast cancer and may not be generalizable to other cancers.
Participant Demographics
98 control individuals and 54 breast cancer patients, age and sex matched.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website